U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit
Feb 15 (Reuters) – The U.S. governing administration must encounter a patent lawsuit in excess of COVID-19 vaccines, not vaccine maker Moderna Inc (MRNA.O), the Division of Justice explained to…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KPO2OJZ2A5KTNBS7VEWJUE5KVA.jpg?ssl=1)





